Cell Culture Market by Product [Consumables (Media, Reagents, Sera, Cell Lines), Equipment (Bioreactor, Centrifuge, Cell Counter)], Application (Bioproduction, Cancer Research, Stem Cell, Diagnostic), and End User (Pharma, Academic) - Global Forecast to 2

Cell Culture Market by Product [Consumables (Media, Reagents, Sera, Cell Lines), Equipment (Bioreactor, Centrifuge, Cell Counter)], Application (Bioproduction, Cancer Research, Stem Cell, Diagnostic), and End User (Pharma, Academic) - Global Forecast to 2029

Cell Culture Market by Product [Consumables (Media, Reagents, Sera, Cell Lines), Equipment (Bioreactor, Centrifuge, Cell Counter)], Application (Bioproduction, Cancer Research, Stem Cell, Diagnostic), and End User (Pharma, Academic) - Global Forecast to 2029

The cell culture market is expected to reach $48.63 billion by 2029, at a CAGR of 11.7% from 2022 to 2029.

After extensive primary and secondary research, the report provides an in-depth analysis of the cell culture market and insights into the key drivers, restraints, challenges, and opportunities in the cell culture market.

The growing demand for monoclonal bodies, increasing prevalence of chronic diseases, funding for cell-based research, rising adoption of single-use technologies, growing demand for biopharmaceuticals, and increasing R&D spending in the life science sector are the major factors driving the growth of this market. Furthermore, the growing adoption of 3D cell culture and personalized medicine to offer new growth potential are expected to provide significant growth opportunities. However, disposal of plastic waste generated from single-use technologies, cell line misidentification and cross contamination, and reproducibility of results challenge the growth of the market up to a certain extent.

Based on product, in 2022, the consumables segment is estimated to account for the largest share of the cell culture market. The large market share of this segment is attributed to the recurrent usage of the consumables such as media, reagents, sera, and cell culture vessels for carrying out the cell culture technique. Additionally, companies are launching products specific to cell type, further supporting cell-specific research studies.

Based on application, in 2022, the bioproduction segment is estimated to account for the largest share of the cell culture market. The large market share of this segment is attributed to the growing demand for biopharmaceutical products and the need for cell culture products for the bioprocessing of these biopharma products. Furthermore, research for novel products such as therapeutic proteins, vaccines, and cell and gene therapy contributes to market growth.

Based on end user, in 2022, the pharmaceutical and biotechnology companies segment is estimated to account for the largest share of the cell culture market. The large market share of this segment is attributed to the increasing research and commercial production of biopharmaceuticals, increasing clinical pipeline, and rising funding for R&D related to cell-based therapies.

An in-depth analysis of the geographical scenario of the cell culture market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, the Middle East & Africa) along with the coverage of major countries in each region. In 2022, North America is estimated to account for the largest share of the cell culture market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The rising healthcare spending, new technologies and advancements in cell culture, increased demand for cell-based diagnosis and treatments, presence of major players, and availability of skilled professionals and best research institutes are the factors contributing to the large share of this regional market.

The key players operating in the cell culture market are Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), PromoCell GmbH (Germany), Cytiva (U.S.), Lonza Group Ltd (Switzerland), Corning Incorporated (U.S.), Becton, Dickinson and Company (U.S.), HiMedia Laboratories (India), Sartorius AG (Germany), Eppendorf SE (Germany), FUJIFILM Holdings Corporation (Japan), Agilent Technologies, Inc. (U.S.), Getinge AB (Sweden), Miltenyi Biotec B.V. & Co. KG (Germany), and Solida Biotech GmBH (Germany).

Scope of the Report:

Cell Culture Market, by Product

Consumables
Media

Cell Culture Media Market, by Physical form

Dry Powder Media
Liquid Media

Cell Culture Media Market, by Type

Off-the-Shelf Media
Custom Media

Cell Culture Media Market, by Source

Chemically Defined Media
Natural Media
Serum-free Media
Classical Media and Salts
Stem Cell Culture Media
Specialty Media
Reagents
Growth Factors and Cytokines
Cryoprotective Reagents
Antibiotics/Antimycotics
Cell Dissociation Reagents
Buffers
Balanced Salt Solutions
Attachment and Matrix Factors
Other Cell Culture Reagents

(Other cell culture reagents include chelators, antioxidants, sugars, vitamins, stains, and dyes)

Cells and Cell Lines
Sera
Fetal Bovine Serum
Other Sera

(Other sera include newborn calf serum, chicken serum, goat serum, rabbit serum, pig serum, mouse serum, sheep serum, rat serum, and horse serum)

Cell Culture Vessels
Cell Culture Dishes
Cell Culture Plates
Cell Culture Flasks
Roller Bottles

Other Cell Culture Vessels

(Other cell culture vessels include pipettes, tips, cuvettes, and tubings)

Equipment
Cryopreservative Containers
Refrigerators and Freezers
Biosafety Cabinets
Incubators
Sterilizers
Bioreactors
Microscopes
Centrifuges
Cell Counters
Water Baths
Other Equipment

(Other equipment includes scales, weighing balance, and pH meter)

Cell Culture Market, by Application

Bioproduction
Monoclonal Antibody Production
Therapeutic Protein Production
Vaccine Production
Cell and Gene therapy
Diagnostics
Cancer Research
Drug Screening and Development
Stem Cell Research

Cell Culture Market, by End User

Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Diagnostic Laboratories

Cell Culture Market, by Geography

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe (RoE)
Asia-Pacific (APAC)
China
Japan
India
Rest of APAC (RoAPAC)
Latin America
Middle East & Africa Cell Culture Market - Report Summary Report Metrics Details Years Considered 2020 - 2029 Base Year 2022 Forecast Period 2022-2029 Page Count 338 Units Referenced Value (USD Million) Segments/Key Topics Market by Product, Market by Application, Market by End User, Market by Geography Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa Key Companies Mentioned Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), Cytiva (U.S.), Lonza Group Ltd. (Switzerland), Corning Incorporated (U.S.), Becton, Dickinson and Company (U.S.), Avantor, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), HiMedia Laboratories (India), Sartorius AG (Germany), Eppendorf SE (Germany), FUJIFILM Holdings Corporation (Japan), Agilent Technologies, Inc. (U.S.), Getinge AB (Sweden), Greiner Bio-One GmbH (Austria), and Miltenyi Biotec B.V. & Co. KG (Germany).

FAQs About the Report

What is the focus of the cell culture market study?

The cell culture market study covers the market sizes & forecasts for various cell culture products used in the life science sector. The report involves the value analysis of various segments and subsegments of the cell culture market at the regional and country levels.

What is the value of revenue generated from sale of cell culture products across the globe? At what rate is their demand expected to grow for the next 5-7 years?

The cell culture market is projected to reach $48.63 billion by 2029, at a CAGR of 11.7% during the forecast period.

Which product segment is estimated to hold the major share and register the highest growth rate in the cell culture market?

Based on product, in 2022, the consumables segment is estimated to account for the largest share of the cell culture market. This segment is also projected to grow at the highest CAGR during the forecast period. The frequent use of these consumables drives the high growth rate of this segment. Additionally, continuous improvements in cell culture media contribute to the growth.

Which end-user segment of the cell culture market is projected to create more traction in the cell culture market?

The pharmaceutical & biotechnology companies segment is projected to register the highest CAGR during the forecast period. The growth of this segment is driven by the proliferation of pharmaceutical & biotechnology companies, rising unmet medical needs in the area of various chronic and rare diseases, and increasing demand for pharmaceutical & biopharmaceutical drugs from emerging countries.

What are the key factors supporting the growth of this market? Also, what are the major opportunities for existing market players and new entrants in the cell culture market?

The growth of this market is driven by factors such as the growth in biopharmaceutical market, increasing prevalence of chronic diseases, growing demand for monoclonal antibodies, increase in research funding, and rising adoption of single-use technologies.

In addition, the growing adoption of 3D cell culture and personalized medicine to offer new growth potential are expected to provide significant opportunities for the growth of this market.

Who are the major players operating in the cell culture market?

The key players operating in the cell culture market are Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), PromoCell GmbH (Germany), Cytiva (U.S.), Lonza Group Ltd (Switzerland), Corning Incorporated (U.S.), Becton, Dickinson and Company (U.S.), HiMedia Laboratories (India), Sartorius AG (Germany), Eppendorf SE (Germany), FUJIFILM Holdings Corporation (Japan), Agilent Technologies, Inc. (U.S.), Getinge AB (Sweden), Miltenyi Biotec B.V. & Co. KG (Germany), and Solida Biotech GmBH (Germany).

Which regions/countries are expected to offer significant growth opportunities for the vendors operating in the cell culture market?

Emerging economies from Asia-Pacific, such as China, are projected to offer significant growth opportunities for vendors operating in this market due to the presence of pharma & biopharma companies, increasing government funding and research & development activities in China, and the growth of CRO and CDMO in the country fostering growth in biotechnology innovations.